LENZ insider filings

LENZ Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-03. Screen LENZ transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 2 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
RA CAPITAL MANAGEMENT, L.P. — 10% owner & RA Capital Healthcare Fund LP — 10% owner & Kolchinsky Peter — 10% owner & Shah Rajeev M. — 10% owner1—3 legs · 2,718,684 sh · $9,134,778—
Chevallard Daniel R. — Chief Financial Officer1——1

Recent insider filings — LENZ Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-11-034Chevallard Daniel R. — Chief Financial OfficerGrant/award (A): 652,063 (derivative) @ $0EDGAR
2026-11-024RA CAPITAL MANAGEMENT, L.P. — 10% owner
RA Capital Healthcare Fund LP — 10% owner
Kolchinsky Peter — 10% owner
Shah Rajeev M. — 10% owner
Sale (S): 2,159,516 @ $3.36 · Sale (S): 451,998 @ $3.36 · Sale (S): 107,170 @ $3.36EDGAR
2026-06-154Guerard Frederic — DirectorGrant/award (A): 22,100 (derivative) @ $0EDGAR
2026-06-154Scheiner Zachary — DirectorGrant/award (A): 22,100 (derivative) @ $0EDGAR
2026-06-154George Jeffrey P. — DirectorGrant/award (A): 22,100 (derivative) @ $0EDGAR
2026-06-154Drapkin Kimberlee C — DirectorGrant/award (A): 22,100 (derivative) @ $0EDGAR
2026-06-154RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund II, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Grant/award (A): 22,100 (derivative) @ $0EDGAR
2026-06-154Thunen Shelley B — DirectorGrant/award (A): 22,100 (derivative) @ $0EDGAR
2026-06-154MCCOLLUM JAMES W — DirectorGrant/award (A): 22,100 (derivative) @ $0EDGAR
2026-03-304George Jeffrey P. — DirectorPurchase (P): 5,592 @ $8.92EDGAR
2026-03-304Schimmelpennink Evert B. — President, CEO and Secretary, DirectorPurchase (P): 28,089 @ $8.95EDGAR
2026-03-304Chevallard Daniel R. — Chief Financial OfficerPurchase (P): 7,500 @ $8.57EDGAR
2026-01-064Odrich Marc — Chief Medical OfficerGrant/award (A): 84,200 (derivative) @ $0 · Grant/award (A): 14,000 (derivative) @ $0EDGAR
2026-01-064Olsson Shawn — Chief Commercial OfficerGrant/award (A): 84,200 (derivative) @ $0 · Grant/award (A): 14,000 (derivative) @ $0EDGAR
2026-01-064Schimmelpennink Evert B. — President, CEO and Secretary, DirectorGrant/award (A): 358,100 (derivative) @ $0EDGAR
2026-01-064Chevallard Daniel R. — Chief Financial OfficerGrant/award (A): 84,200 (derivative) @ $0 · Grant/award (A): 14,000 (derivative) @ $0EDGAR
2025-11-194Olsson Shawn — Chief Commercial OfficerOption exercise (M): 10,000 @ $2.08 · Sale (S): 4,212 @ $25.74 · Sale (S): 5,788 @ $26.37 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2025-11-104MCCOLLUM JAMES W — DirectorPurchase (P): 10,500 @ $22.79EDGAR
2025-11-074Chevallard Daniel R. — Chief Financial OfficerPurchase (P): 20 @ $22.71 · Purchase (P): 2,178 @ $22.76EDGAR
2025-10-024Versant Venture Capital VI, L.P. — 10% owner
Versant Ventures VI GP, L.P. — 10% owner
Versant Ventures VI GP-GP, LLC — 10% owner
Versant Vantage II, L.P. — 10% owner
Versant Vantage II GP, L.P. — 10% owner
Versant Vantage II GP-GP, LLC — 10% owner
Versant Venture Capital VII, L.P. — 10% owner
Versant Ventures VII GP, L.P. — 10% owner
Versant Ventures VII GP-GP, LLC — 10% owner
Sale (S): 49,701 @ $45.35 · Sale (S): 34,405 @ $45.35 · Sale (S): 83,066 @ $46.41 · Sale (S): 57,502 @ $46.41 · Sale (S): 177 @ $47.01 · Sale (S): 123 @ $47.01EDGAR
2025-09-224Versant Venture Capital VI, L.P. — 10% owner
Versant Ventures VI GP, L.P. — 10% owner
Versant Ventures VI GP-GP, LLC — 10% owner
Versant Vantage II, L.P. — 10% owner
Versant Vantage II GP, L.P. — 10% owner
Versant Vantage II GP-GP, LLC — 10% owner
Versant Venture Capital VII, L.P. — 10% owner
Versant Ventures VII GP, L.P. — 10% owner
Versant Ventures VII GP-GP, LLC — 10% owner
Sale (S): 49,479 @ $41.59 · Sale (S): 24,370 @ $41.59 · Sale (S): 40,907 @ $43.00 · Sale (S): 20,148 @ $43.00 · Sale (S): 268 @ $43.30 · Sale (S): 132 @ $43.30EDGAR
2025-08-264Versant Venture Capital VI, L.P. — 10% owner
Versant Ventures VI GP, L.P. — 10% owner
Versant Ventures VI GP-GP, LLC — 10% owner
Versant Vantage II, L.P. — 10% owner
Versant Vantage II GP, L.P. — 10% owner
Versant Vantage II GP-GP, LLC — 10% owner
Versant Venture Capital VII, L.P. — 10% owner
Versant Ventures VII GP, L.P. — 10% owner
Versant Ventures VII GP-GP, LLC — 10% owner
Sale (S): 20,493 @ $40.03 · Sale (S): 10,076 @ $40.03 · Sale (S): 5,668 @ $40.59 · Sale (S): 2,809 @ $40.59 · Sale (S): 50,270 @ $39.53 · Sale (S): 24,760 @ $39.53 · +6 moreEDGAR
2025-08-194Versant Venture Capital VI, L.P. — 10% owner
Versant Ventures VI GP, L.P. — 10% owner
Versant Ventures VI GP-GP, LLC — 10% owner
Versant Vantage II, L.P. — 10% owner
Versant Vantage II GP, L.P. — 10% owner
Versant Vantage II GP-GP, LLC — 10% owner
Versant Venture Capital VII, L.P. — 10% owner
Versant Ventures VII GP, L.P. — 10% owner
Versant Ventures VII GP-GP, LLC — 10% owner
Sale (S): 145,051 @ $39.50 · Sale (S): 69,949 @ $39.50 · Sale (S): 30,628 @ $38.56 · Sale (S): 15,085 @ $38.56EDGAR
2025-07-144Versant Venture Capital VI, L.P. — 10% owner
Versant Ventures VI GP, L.P. — 10% owner
Versant Ventures VI GP-GP, LLC — 10% owner
Versant Vantage II, L.P. — 10% owner
Versant Vantage II GP, L.P. — 10% owner
Versant Vantage II GP-GP, LLC — 10% owner
Versant Venture Capital VII, L.P. — 10% owner
Versant Ventures VII GP, L.P. — 10% owner
Versant Ventures VII GP-GP, LLC — 10% owner
Sale (S): 191,376 @ $34EDGAR
2025-07-014Versant Venture Capital VI, L.P. — 10% owner
Versant Ventures VI GP, L.P. — 10% owner
Versant Ventures VI GP-GP, LLC — 10% owner
Versant Vantage II, L.P. — 10% owner
Versant Vantage II GP, L.P. — 10% owner
Versant Vantage II GP-GP, LLC — 10% owner
Versant Venture Capital VII, L.P. — 10% owner
Versant Ventures VII GP, L.P. — 10% owner
Versant Ventures VII GP-GP, LLC — 10% owner
Sale (S): 200,000 @ $30.46EDGAR
2025-06-204Versant Venture Capital VI, L.P. — 10% owner
Versant Ventures VI GP, L.P. — 10% owner
Versant Ventures VI GP-GP, LLC — 10% owner
Versant Vantage II, L.P. — 10% owner
Versant Vantage II GP, L.P. — 10% owner
Versant Vantage II GP-GP, LLC — 10% owner
Versant Venture Capital VII, L.P. — 10% owner
Versant Ventures VII GP, L.P. — 10% owner
Versant Ventures VII GP-GP, LLC — 10% owner
Sale (S): 100,000 @ $29.95 · Sale (S): 100,877 @ $30.35 · Sale (S): 133,924 @ $30.25EDGAR
2025-06-124Versant Venture Capital VI, L.P. — 10% owner
Versant Ventures VI GP, L.P. — 10% owner
Versant Ventures VI GP-GP, LLC — 10% owner
Versant Vantage II, L.P. — 10% owner
Versant Vantage II GP, L.P. — 10% owner
Versant Vantage II GP-GP, LLC — 10% owner
Versant Venture Capital VII, L.P. — 10% owner
Versant Ventures VII GP, L.P. — 10% owner
Versant Ventures VII GP-GP, LLC — 10% owner
Sale (S): 350,000 @ $29EDGAR
2025-06-114Guerard Frederic — DirectorGrant/award (A): 13,500 (derivative) @ $0EDGAR
2025-06-114Scheiner Zachary — DirectorGrant/award (A): 13,500 (derivative) @ $0EDGAR
2025-06-114George Jeffrey P. — DirectorGrant/award (A): 13,500 (derivative) @ $0EDGAR
2025-06-114Drapkin Kimberlee C — DirectorGrant/award (A): 13,500 (derivative) @ $0EDGAR
2025-06-114RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund II, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Grant/award (A): 13,500 (derivative) @ $0EDGAR
2025-06-114Thunen Shelley B — DirectorGrant/award (A): 13,500 (derivative) @ $0EDGAR
2025-06-114MCCOLLUM JAMES W — DirectorGrant/award (A): 13,500 (derivative) @ $0EDGAR
2025-04-094Olsson Shawn — Chief Commercial OfficerOption exercise (M): 1,400 @ $2.08 · Option exercise (M): 1,400 (derivative) @ $0EDGAR
2025-03-074Schimmelpennink Evert B. — President, CEO and Secretary, DirectorOption exercise (M): 4,200 @ $1.04 · Option exercise (M): 4,200 (derivative) @ $0EDGAR
2024-12-174Olsson Shawn — Chief Commercial OfficerOption exercise (M): 3,333 @ $2.08 · Option exercise (M): 3,333 (derivative) @ $0EDGAR
2024-07-234Schimmelpennink Evert B. — President, CEO and Secretary, DirectorOption exercise (M): 45,000 @ $1.04 · Option exercise (M): 45,000 (derivative) @ $0EDGAR
2024-05-154Chevallard Daniel R. — Chief Financial OfficerPurchase (P): 3,188 @ $15.68EDGAR
2024-05-144MCCOLLUM JAMES W — DirectorPurchase (P): 31,332 @ $15.99EDGAR
2024-03-254Odrich Marc — Chief Medical OfficerGrant/award (A): 99,599 @ $0 · Grant/award (A): 66,472 (derivative) @ $0 · Grant/award (A): 105,000 (derivative) @ $0EDGAR
2024-03-254Scheiner Zachary — DirectorGrant/award (A): 27,000 (derivative) @ $0EDGAR
2024-03-254George Jeffrey P. — DirectorGrant/award (A): 27,000 (derivative) @ $0EDGAR
2024-03-254Schimmelpennink Evert B. — President, CEO and Secretary, DirectorGrant/award (A): 387,106 (derivative) @ $0 · Grant/award (A): 82,723 (derivative) @ $0 · Grant/award (A): 315,864 (derivative) @ $0 · Grant/award (A): 475,000 (derivative) @ $0EDGAR
2024-03-254Chevallard Daniel R. — Chief Financial OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2024-03-254Versant Venture Capital VI, L.P. — 10% owner
Versant Ventures VI GP, L.P. — 10% owner
Versant Ventures VI GP-GP, LLC — 10% owner
Versant Vantage II, L.P. — 10% owner
Versant Vantage II GP, L.P. — 10% owner
Versant Vantage II GP-GP, LLC — 10% owner
Versant Venture Capital VII, L.P. — 10% owner
Versant Ventures VII GP, L.P. — 10% owner
Versant Ventures VII GP-GP, LLC — 10% owner
Other (J): 598,203EDGAR
2024-03-254Drapkin Kimberlee C — DirectorGrant/award (A): 27,000 (derivative) @ $0EDGAR
2024-03-254RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund II, L.P. — Director, 10% owner
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Grant/award (A): 2,386,301 · Grant/award (A): 694,755 · Grant/award (A): 164,729 · Purchase (P): 933,038 @ $15.03 · Purchase (P): 64,971 @ $15.03 · Grant/award (A): 54,582 (derivative) · +3 moreEDGAR
2024-03-254Thunen Shelley B — DirectorGrant/award (A): 27,000 (derivative) @ $0EDGAR
2024-03-254MCCOLLUM JAMES W — DirectorGrant/award (A): 95,034 @ $0 · Grant/award (A): 477,600 @ $0 · Grant/award (A): 16,633 @ $15.03 · Grant/award (A): 6,575 (derivative) @ $0 · Grant/award (A): 27,000 (derivative) @ $0EDGAR

Recent 8-K events — LENZ Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-10-288-K2.02 — Results of Operations and Financial Condition
?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-128-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-248-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-128-K8.01 — Other EventsEDGAR
2025-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-088-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=LENZ returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs